New research reveals that people who come off blockbuster weight-loss injections like Wegovy and Mounjaro may regain reduced body mass much more quickly than those who end traditional lifestyle plans.
Published data in a leading medical journal shows that while overweight individuals frequently drop about a fifth of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month upon discontinuation.
"Individuals using such drugs must be aware of the danger of fast weight regain when the therapy is stopped," cautioned expert Dr. Susan Jebb.
This pace of recovery implies a reversion to original mass within about a year and a half.
Analyzing Therapies
The research, which looked at dozens of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with other pills.
The team point out that people who lose weight through lifestyle changes alone generally have a less rapid creep back—perhaps 100 grams monthly—after stopping.
Explaining the Rapid Regain
Nutrition scientists believe the mode of action of the injections accounts for the heightened rebound.
These medications copy a natural hormone called glucagon-like peptide-1, which controls feelings of fullness.
"Long-term administration of GLP-1 concentrations far above than normal might result in the body to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this hormone supplement means hunger is uncontrolled, making excessive eating much more probable."
An Ongoing Issue?
Medical guidelines suggest the jabs for people with weight-linked medical conditions, alongside recommended lifestyle changes.
Professionals contend that, due to the high risk of relapse, the treatment should be considered life-long.
This perspective is echoed by drug manufacturers, who say that the results "highlight the chronic nature of excess weight," similar to managing conditions like diabetes.
Patient Accounts
Users who have come off the medication report a powerful resurgence of appetite.
"I experienced a trigger that goes on and I was suddenly extremely hungry," said an individual.
This challenge is compounded if individuals have not established permanent dietary or behavioural changes during therapy.
Widespread Adoption
Recent estimates suggest that millions of people in the UK have tried these injections in the past year, with demand continuing to grow.
- Adoption is greater among women than males.
- The 40s and 50s demographic shows the highest usage rates.
- Many access the drugs through private healthcare rather than the NHS.
Ultimately, clinicians stress that while these medications are powerful tools for weight loss, they are not a standalone cure and long-term success likely depends on integrated lifestyle support.
